Episindan

Product TA

Antineoplastic

Active Ingredient

Epirubicin

Route Of Administration

IV

Product type

Specialty


Product Details

Specialty

Oncology

Strength

10 mg

Product Form

Vial

Registration Number

DKI1131701144A1

Product Details

Specialty

Oncology

Strength

50 mg

Product Form

Vial

Registration Number

DKI1131701144B1

Additional products

Plaxat

Product TA

Antineoplastic

Active Ingredient

Oxaliplatin

Route Of Administration

IV

Product type

Specialty
View Product

Lezra

Product TA

Antineoplastic

Active Ingredient

Letrozole

Route Of Administration

Oral

Product type

Specialty
View Product

Page Last Updated: 05 October 2021